Your browser doesn't support javascript.
loading
NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotype.
Hong, Seung-Woo; Shin, Jae-Sik; Moon, Jai-Hee; Kim, Ye-Seul; Lee, Jooyoung; Choi, Eun Kyoung; Ha, Seung-Hee; Lee, Dae Hee; Chung, Ha Na; Kim, Jeong Eun; Kim, Kyu-Pyo; Hong, Yong Sang; Lee, Jae-Lyun; Lee, Wang-Jae; Choi, Eun Kyung; Lee, Jung Shin; Jin, Dong-Hoon; Kim, Tae Won.
Affiliation
  • Hong SW; Innovative Cancer Research, Asan Institute for Life Science, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.
Apoptosis ; 19(5): 895-904, 2014 May.
Article in En | MEDLINE | ID: mdl-24652480

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Quinolines / Apoptosis / PTEN Phosphohydrolase / TOR Serine-Threonine Kinases / Phosphoinositide-3 Kinase Inhibitors / Imidazoles / Antineoplastic Agents Limits: Humans / Male Language: En Journal: Apoptosis Year: 2014 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Quinolines / Apoptosis / PTEN Phosphohydrolase / TOR Serine-Threonine Kinases / Phosphoinositide-3 Kinase Inhibitors / Imidazoles / Antineoplastic Agents Limits: Humans / Male Language: En Journal: Apoptosis Year: 2014 Type: Article